Condition
Triple Negative Breast Cancer Metastatic clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Triple Negative Breast Cancer Metastatic clinical trials that are recruiting, at sites in 2 countries (most in China (1), Italy (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Combining multimodal tumor ablation with immunotherapy for liver metastases
This trial will test whether adding the immunotherapy drug pucotenlimab to multimodal thermal ablation helps people with liver metastases from colorectal cancer, triple-negative breast cancer, or melanoma.
-
Restoring immunotherapy sensitivity in advanced triple negative breast cancer
This study is testing a new combination of treatments to see if it can help people with advanced triple negative breast cancer whose tumors have come back after earlier treatments.
Related topics
Quick answers
How many Triple Negative Breast Cancer Metastatic clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.